NasdaqGM - Nasdaq Real Time Price USD
Relay Therapeutics, Inc. (RLAY)
2.9500
-0.2000
(-6.35%)
At close: May 7 at 4:00:01 PM EDT
3.0000
+0.05
+(1.69%)
Pre-Market: 5:10:45 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,679
10,007
25,546
1,381
3,029
Operating Expense
386,027
395,681
404,968
312,333
230,036
Operating Income
-378,348
-385,674
-379,422
-310,952
-227,007
Net Non Operating Interest Income Expense
33,608
34,746
31,045
8,786
830
Other Income Expense
11,354
13,220
6,404
11,657
-137,695
Pretax Income
-333,386
-337,708
-341,973
-290,509
-363,872
Net Income Common Stockholders
-333,386
-337,708
-341,973
-290,509
-363,872
Diluted NI Available to Com Stockholders
-333,386
-337,708
-341,973
-290,509
-363,872
Basic EPS
-2.20
--
-2.79
-2.59
-3.82
Diluted EPS
-2.20
--
-2.79
-2.59
-3.82
Basic Average Shares
152,465.3800
--
122,576.5270
112,233.6490
95,136.7190
Diluted Average Shares
152,465.3800
--
122,576.5270
112,233.6490
95,136.7190
Total Operating Income as Reported
-366,974
-372,468
-373,000
-299,275
-364,698
Total Expenses
386,027
395,681
404,968
312,333
230,036
Net Income from Continuing & Discontinued Operation
-333,386
-337,708
-341,973
-290,509
-363,872
Normalized Income
-344,760
-350,914
-348,395
-302,186
-226,181
Interest Income
33,608
34,746
31,045
8,786
830
Net Interest Income
33,608
34,746
31,045
8,786
830
EBIT
-378,348
-385,674
-379,422
-310,952
-227,007
EBITDA
-373,071
-380,210
-374,153
-306,822
-223,082
Reconciled Depreciation
5,277
5,464
5,269
4,130
3,925
Net Income from Continuing Operation Net Minority Interest
-333,386
-337,708
-341,973
-290,509
-363,872
Total Unusual Items Excluding Goodwill
11,374
13,206
6,422
11,677
-137,691
Total Unusual Items
11,374
13,206
6,422
11,677
-137,691
Normalized EBITDA
-384,445
-393,416
-380,575
-318,499
-85,391
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KYMR Kymera Therapeutics, Inc.
29.11
+1.89%
RVMD Revolution Medicines, Inc.
37.66
+0.59%
BPMC Blueprint Medicines Corporation
99.80
+0.65%
DAWN Day One Biopharmaceuticals, Inc.
6.30
-9.87%
ARVN Arvinas, Inc.
6.67
-4.03%
NUVB Nuvation Bio Inc.
2.0400
-2.39%
NRIX Nurix Therapeutics, Inc.
9.30
-3.58%
SNDX Syndax Pharmaceuticals, Inc.
9.99
-6.11%
STOK Stoke Therapeutics, Inc.
8.66
-1.03%
NUVL Nuvalent, Inc.
66.72
-2.16%